Tg(NPHS2-Trpc6*E896K)F75aWalz
Transgene Detail
|
Symbol: |
Tg(NPHS2-Trpc6*E896K)F75aWalz |
Name: |
transgene insertion F75a, Katherina Walz |
MGI ID: |
MGI:5319640 |
Synonyms: |
Trpc6-HA E896K |
Transgene: |
Tg(NPHS2-Trpc6*E896K)F75aWalz Location: unknown
|
Alliance: |
Tg(NPHS2-Trpc6*E896K)F75aWalz page
|
|
Strain of Origin: |
C57BL/6J x CBA/J
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(NPHS2-Trpc6*E896K)F75aWalz expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Note |
mouse |
Trpc6 (MGI:109523) |
|
|
|
|
Mutation details: The Trpc6-HA wildtype cDNA sequence was made by modifying a Trpc6 cDNA sequence (encoding a 930 amino acid protein) originally isolated from mouse brain tissue by both repairing an A2615G point mutation (D872G) and also by in-frame addition of an influenza virus hemaglutinin epitope (HA-tag) at the 3' end. The cDNA sequence was placed downstream of a 2.5 kbp fragment from the promoter/enhancer region of the human podocin locus (NPHS2) and upstream from a bovine growth hormone polyA sequence. The G2686A nucleotide substitution was introduced to produce the amino acid substitution of lysine for glutamic acid at position 896 (E896K). Lines F73a and F75a were generated.
(J:165112)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:165112 Krall P, et al., Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS One. 2010;5(9):e12859 |
All: |
1 reference(s) |
|